antiretroviral therapy; antiviral activity; bioinformatics; Chinese medicine; chronic inflammation; coronavirus disease 2019/dt [Drug Therapy]; COVID-19 pharmacotherapy; economic aspect; Fallopia multiflora; human; Human immunodeficiency virus infection; influenza; letter; Lycoris radiata; malaria; mortality rate; pandemic; Rheum officinale; rheumatoid arthritis; Severe acute respiratory syndrome coronavirus 2; virus load; azithromycin/dt [Drug Therapy]; beta interferon/dt [Drug Therapy]; chloroquine/dt [Drug Therapy]; favipiravir/dt [Drug Therapy]; hydroxychloroquine/dt [Drug Therapy]; lopinavir plus ritonavir/dt [Drug Therapy]; monoclonal antibody/dt [Drug Therapy]; natural product/dt [Drug Therapy]; remdesivir/dt [Drug Therapy]; umifenovir/dt [Drug Therapy]